Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Prashker

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Rheumatology|March 1, 1994
Health care research and policy studiesM J Prashker
Current Opinion in Rheumatology|March 1, 1996
Health services research and policy studiesM J Prashker
Current Opinion in Rheumatology|March 1, 1995
Health care research and policy studiesM J Prashker
Annals of Internal Medicine|November 1, 1991
Subspecialty training: is it financially worthwhile?M J Prashker, R F Meenan
Arthritis and Rheumatism|March 1, 1995
The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicityM J Prashker, R F Meenan
Archives of Internal Medicine|March 29, 2000
Should noncardiac chest pain be treated empirically? A cost-effectiveness analysisA M Borzecki, M C Pedrosa, M J Prashker
Medical Care|April 27, 1999
More or less?: Methods to compare VA and non-VA health care costsA M Hendricks, D K Remler, M J Prashker
Pharmacoeconomics|November 4, 1994
The costs of rheumatoid arthritisS H Allaire, M J Prashker, R F Meenan
Arthritis and Rheumatism|March 1, 1995
The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexateS R Bergquist, D T Felson, M J Prashker, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Rheumatology|March 1, 1994
Health care research and policy studiesM J Prashker
Current Opinion in Rheumatology|March 1, 1996
Health services research and policy studiesM J Prashker
Current Opinion in Rheumatology|March 1, 1995
Health care research and policy studiesM J Prashker
Annals of Internal Medicine|November 1, 1991
Subspecialty training: is it financially worthwhile?M J Prashker, R F Meenan
Arthritis and Rheumatism|March 1, 1995
The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicityM J Prashker, R F Meenan
Archives of Internal Medicine|March 29, 2000
Should noncardiac chest pain be treated empirically? A cost-effectiveness analysisA M Borzecki, M C Pedrosa, M J Prashker
Medical Care|April 27, 1999
More or less?: Methods to compare VA and non-VA health care costsA M Hendricks, D K Remler, M J Prashker
Pharmacoeconomics|November 4, 1994
The costs of rheumatoid arthritisS H Allaire, M J Prashker, R F Meenan
Arthritis and Rheumatism|March 1, 1995
The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexateS R Bergquist, D T Felson, M J Prashker, et al.
Pageof 1